Opinion/decision on a Paediatric investigation plan (PIP): Fasenra, Benralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P

Opinion/decision on a Paediatric investigation plan (PIP): Fasenra, Benralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P/0038/2022

Human medicines European public assessment report (EPAR): Conbriza, bazedoxifene, Date of authorisation: 17/04/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Conbriza, bazedoxifene, Date of authorisation: 17/04/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Vipdomet, alogliptin,metformin, Date of authorisation: 18/09/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Vipdomet, alogliptin,metformin, Date of authorisation: 18/09/2013, Revision: 13, Status: Authorised

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products

Standard operating procedure for validation, publication, and maintenance of real-world data sources and studies in the HMA-EMA RWD Catalogues

Standard operating procedure for validation, publication, and maintenance of real-world data sources and studies in the HMA-EMA RWD Catalogues

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.